Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Invitae Corp (NVTA) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Invitae Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 1501134.
Total stock buying since 2015: $13,413,448.
Total stock sales since 2015: $72,448,028.
Total stock option exercises since 2015: $2,613,591.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 187,288 | $263,627 | 0 | $0 |
| 2022 | 0 | $0 | 255,954 | $1,119,236 | 0 | $0 |
| 2021 | 0 | $0 | 380,076 | $12,817,977 | 127,308 | $850,813 |
| 2020 | 0 | $0 | 1,249,942 | $50,130,295 | 205,013 | $1,610,049 |
| 2019 | 0 | $0 | 336,020 | $7,311,263 | 10,000 | $99,000 |
| 2018 | 1,155,555 | $5,199,997 | 65,781 | $549,756 | 0 | $0 |
| 2017 | 0 | $0 | 10,628 | $102,624 | 1,666 | $2,099 |
| 2016 | 824,999 | $4,956,574 | 18,721 | $153,250 | 16,500 | $51,630 |
| 2015 | 224,899 | $3,256,877 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-06 | 0 | $0 | 14,165 | $19,504 | 0 | $0 |
| 2023-05 | 0 | $0 | 163,395 | $230,408 | 0 | $0 |
| 2023-03 | 0 | $0 | 9,728 | $13,715 | 0 | $0 |
| 2022-12 | 0 | $0 | 55,979 | $114,631 | 0 | $0 |
| 2022-08 | 0 | $0 | 39,433 | $179,418 | 0 | $0 |
| 2022-05 | 0 | $0 | 85,931 | $326,268 | 0 | $0 |
| 2022-03 | 0 | $0 | 74,611 | $498,919 | 0 | $0 |
| 2021-11 | 0 | $0 | 29,675 | $649,556 | 29,675 | $298,678 |
| 2021-10 | 0 | $0 | 3,675 | $103,120 | 0 | $0 |
| 2021-09 | 0 | $0 | 7,350 | $234,303 | 55,000 | $333,300 |
| 2021-08 | 0 | $0 | 71,004 | $1,796,210 | 0 | $0 |
| 2021-07 | 0 | $0 | 3,675 | $108,008 | 0 | $0 |
| 2021-06 | 0 | $0 | 89,820 | $2,825,479 | 0 | $0 |
| 2021-05 | 0 | $0 | 20,868 | $393,570 | 0 | $0 |
| 2021-04 | 0 | $0 | 23,568 | $935,120 | 0 | $0 |
| 2021-03 | 0 | $0 | 107,567 | $4,596,155 | 23,333 | $29,399 |
| 2021-02 | 0 | $0 | 10,000 | $488,620 | 0 | $0 |
| 2021-01 | 0 | $0 | 12,874 | $687,836 | 19,300 | $189,436 |
| 2020-12 | 0 | $0 | 717,977 | $36,218,583 | 20,000 | $254,200 |
| 2020-11 | 0 | $0 | 50,110 | $2,357,088 | 35,000 | $331,710 |
| 2020-10 | 0 | $0 | 1,000 | $51,360 | 6,550 | $64,845 |
| 2020-09 | 0 | $0 | 27,058 | $917,551 | 0 | $0 |
| 2020-08 | 0 | $0 | 89,979 | $2,885,213 | 0 | $0 |
| 2020-07 | 0 | $0 | 80,283 | $2,728,321 | 37,500 | $158,350 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-13 | Brida Thomas (See Remarks) | Sale | 7,079 | 1.38 | 9,747 |
| 2023-06-13 | Nussbaum Robert L (Chief Medical Officer) | Sale | 7,086 | 1.38 | 9,757 |
| 2023-05-16 | Wen Yafei (Chief Financial Officer) | Sale | 43,452 | 1.99 | 86,599 |
| 2023-05-16 | Knight Kenneth D. (Chief Executive Officer) | Sale | 45,432 | 1.20 | 54,472 |
| 2023-05-16 | Brida Thomas (See Remarks) | Sale | 26,476 | 1.20 | 31,744 |
| 2023-05-16 | Nussbaum Robert L (Chief Medical Officer) | Sale | 26,476 | 1.20 | 31,744 |
| 2023-05-16 | Werner Robert F. (Chief Accounting Officer) | Sale | 21,559 | 1.20 | 25,849 |
| 2023-03-13 | Wen Yafei (Chief Financial Officer) | Sale | 2,625 | 1.41 | 3,701 |
| 2023-03-13 | Knight Kenneth D. (Chief Executive Officer) | Sale | 1,853 | 1.41 | 2,612 |
| 2023-03-13 | Brida Thomas (See Remarks) | Sale | 2,625 | 1.41 | 3,701 |
| 2023-03-13 | Nussbaum Robert L (Chief Medical Officer) | Sale | 2,625 | 1.41 | 3,701 |
| 2022-12-19 | George Sean E (Director) | Sale | 11,163 | 2.08 | 23,207 |
| 2022-12-16 | George Sean E (Director) | Sale | 44,816 | 2.04 | 91,424 |
| 2022-08-16 | Brida Thomas (See remarks) | Sale | 7,048 | 4.55 | 32,068 |
| 2022-08-16 | Nussbaum Robert L (Chief Medical Officer) | Sale | 7,048 | 4.55 | 32,068 |
| 2022-08-16 | George Sean E (Director) | Sale | 22,085 | 4.55 | 100,486 |
| 2022-08-16 | Werner Robert F. (Chief Accounting Officer) | Sale | 3,252 | 4.55 | 14,796 |
| 2022-05-19 | Werner Robert F. (Chief Accounting Officer) | Sale | 2,746 | 3.40 | 9,336 |
| 2022-05-17 | Wen Yafei (Chief Financial Officer) | Sale | 17,042 | 3.81 | 64,930 |
| 2022-05-17 | Knight Kenneth D. (Chief Operating Officer) | Sale | 28,295 | 3.81 | 107,803 |
| 2022-05-17 | Brida Thomas (See Remarks) | Sale | 6,098 | 3.81 | 23,233 |
| 2022-05-17 | Nussbaum Robert L (Chief Medical Officer) | Sale | 6,098 | 3.81 | 23,233 |
| 2022-05-17 | George Sean E (President & CEO) | Sale | 18,296 | 3.81 | 69,707 |
| 2022-05-17 | Werner Robert F. (Chief Accounting Officer) | Sale | 7,356 | 3.81 | 28,026 |
| 2022-03-14 | Wen Yafei (Chief Financial Officer) | Sale | 3,289 | 6.69 | 21,993 |
| 2022-03-14 | Knight Kenneth D. (Chief Operating Officer) | Sale | 2,358 | 6.69 | 15,765 |
| 2022-03-14 | Brida Thomas (General Counsel) | Sale | 17,987 | 6.69 | 120,279 |
| 2022-03-14 | Nussbaum Robert L (Chief Medical Officer) | Sale | 19,588 | 6.69 | 130,984 |
| 2022-03-14 | George Sean E (President & CEO) | Sale | 31,389 | 6.69 | 209,898 |
| 2021-11-11 | Nussbaum Robert L (Chief Medical Officer) | Sale | 29,675 | 21.89 | 649,556 |
| 2021-11-11 | Nussbaum Robert L (Chief Medical Officer) | Option Ex | 29,675 | 10.06 | 298,678 |
| 2021-10-22 | George Sean E (President & CEO) | Sale | 3,675 | 28.06 | 103,120 |
| 2021-09-27 | George Sean E (President & CEO) | Option Ex | 55,000 | 6.06 | 333,300 |
| 2021-09-22 | George Sean E (President & CEO) | Sale | 7,350 | 31.88 | 234,303 |
| 2021-08-19 | Werner Robert F. (Chief Accounting Officer) | Sale | 15,337 | 24.86 | 381,323 |
| 2021-08-16 | Brida Thomas (General Counsel) | Sale | 14,438 | 25.42 | 366,970 |
| 2021-08-16 | Nussbaum Robert L (Chief Medical Officer) | Sale | 21,231 | 25.42 | 539,628 |
| 2021-08-16 | George Sean E (President & CEO) | Sale | 16,986 | 25.42 | 431,733 |
| 2021-08-16 | Werner Robert F. (Chief Accounting Officer) | Sale | 3,012 | 25.42 | 76,556 |
| 2021-07-22 | George Sean E (President & CEO) | Sale | 3,675 | 29.39 | 108,008 |
| 2021-06-22 | George Sean E (President & CEO) | Sale | 3,675 | 33.02 | 121,363 |
| 2021-06-15 | Knight Kenneth D. (Chief Operating Officer) | Sale | 14,874 | 30.30 | 450,682 |
| 2021-06-14 | Brida Thomas (General Counsel) | Sale | 9,910 | 31.62 | 313,403 |
| 2021-06-14 | Stueland Katherine (Chief Commercial Officer) | Sale | 20,340 | 31.60 | 642,744 |
| 2021-06-14 | Nussbaum Robert L (Chief Medical Officer) | Sale | 9,910 | 31.62 | 313,403 |
| 2021-06-14 | George Sean E (President & CEO) | Sale | 21,201 | 31.62 | 670,481 |
| 2021-06-14 | Guyer Shelly D (Chief Financial Officer) | Sale | 9,910 | 31.62 | 313,403 |
| 2021-05-20 | George Sean E (President & CEO) | Sale | 3,675 | 28.00 | 102,900 |
| 2021-05-20 | Werner Robert F. (Chief Accounting Officer) | Sale | 7,116 | 27.62 | 196,558 |
| 2021-05-18 | Werner Robert F. (Chief Accounting Officer) | Sale | 6,653 | .00 | 0 |
| 2021-05-18 | Guyer Shelly D (Chief Financial Officer) | Sale | 3,424 | 27.49 | 94,112 |
| 2021-04-22 | George Sean E (President & CEO) | Sale | 3,675 | 36.55 | 134,328 |
| 2021-04-14 | Stueland Katherine (Chief Commercial Officer) | Sale | 19,893 | 40.26 | 800,792 |
| 2021-03-22 | George Sean E (President & CEO) | Sale | 3,675 | 42.72 | 157,007 |
| 2021-03-15 | Stueland Katherine (Chief Commercial Officer) | Sale | 12,443 | 42.90 | 533,817 |
| 2021-03-15 | George Sean E (President & CEO) | Sale | 27,417 | 42.90 | 1,176,216 |
| 2021-03-15 | Guyer Shelly D (Chief Financial Officer) | Sale | 18,147 | 42.90 | 778,524 |
| 2021-03-12 | Brida Thomas (General Counsel) | Sale | 16,051 | 42.90 | 688,603 |
| 2021-03-12 | Nussbaum Robert L (Chief Medical Officer) | Sale | 18,159 | 42.90 | 779,039 |
| 2021-03-09 | George Sean E (President & CEO) | Option Ex | 23,333 | 1.26 | 29,399 |
| 2021-03-04 | George Sean E (President & CEO) | Sale | 3,675 | 37.62 | 138,271 |
| 2021-03-02 | Guyer Shelly D (Chief Financial Officer) | Sale | 3,000 | 43.34 | 130,008 |
| 2021-03-01 | Brida Thomas (General Counsel) | Sale | 5,000 | 42.93 | 214,670 |
| 2021-02-22 | Crouse Geoffrey (Director) | Sale | 10,000 | 48.86 | 488,620 |
| 2021-01-21 | George Sean E (President & CEO) | Sale | 8,675 | 54.52 | 472,969 |
| 2021-01-21 | George Sean E (President & CEO) | Option Ex | 5,000 | 8.70 | 43,500 |
| 2021-01-13 | Stueland Katherine (Chief Commercial Officer) | Sale | 4,199 | 51.17 | 214,867 |
| 2021-01-13 | Stueland Katherine (Chief Commercial Officer) | Option Ex | 4,199 | 10.94 | 45,937 |
| 2021-01-06 | Nussbaum Robert L (Chief Medical Officer) | Option Ex | 10,101 | 9.90 | 99,999 |
| 2020-12-30 | George Sean E (President & CEO) | Option Ex | 10,000 | 1.26 | 12,600 |
| 2020-12-24 | Knight Kenneth D. (Chief Operating Officer) | Sale | 3,622 | 50.50 | 182,911 |
| 2020-12-24 | Myers Jason W. (Director) | Sale | 48,971 | 48.85 | 2,392,331 |
| 2020-12-23 | Myers Jason W. (Director) | Sale | 125,181 | 52.90 | 6,621,699 |
| 2020-12-22 | Myers Jason W. (Director) | Sale | 124,991 | 53.07 | 6,633,022 |
| 2020-12-22 | George Sean E (President & CEO) | Sale | 3,675 | 52.85 | 194,234 |
| 2020-12-21 | Myers Jason W. (Director) | Sale | 99,974 | 48.93 | 4,891,627 |
| 2020-12-18 | Myers Jason W. (Director) | Sale | 131,351 | 48.11 | 6,319,822 |
| 2020-12-17 | Myers Jason W. (Director) | Sale | 50,692 | 47.38 | 2,401,837 |
| 2020-12-16 | Knight Kenneth D. (Chief Operating Officer) | Sale | 13,351 | 51.00 | 680,901 |
| 2020-12-16 | Myers Jason W. (Director) | Sale | 71,869 | 47.32 | 3,400,912 |
| 2020-12-16 | Aguiar Eric (Director) | Sale | 10,000 | 51.10 | 511,019 |
| 2020-12-16 | Aguiar Eric (Director) | Option Ex | 10,000 | 24.16 | 241,600 |
| 2020-12-14 | Stueland Katherine (Chief Commercial Officer) | Sale | 34,300 | 57.97 | 1,988,268 |
| 2020-11-24 | Werner Robert F. (Chief Accounting Officer) | Sale | 2,427 | 49.59 | 120,354 |
| 2020-11-20 | George Sean E (President & CEO) | Sale | 8,683 | 47.85 | 415,455 |
| 2020-11-20 | George Sean E (President & CEO) | Option Ex | 5,000 | 8.70 | 43,500 |
| 2020-11-18 | Guyer Shelly D (Chief Financial Officer) | Sale | 3,000 | 47.09 | 141,279 |
| 2020-11-17 | Brida Thomas (General Counsel) | Sale | 5,000 | 46.17 | 230,850 |
| 2020-11-16 | Aguiar Eric | Sale | 30,000 | 46.70 | 1,401,150 |
| 2020-11-16 | Aguiar Eric | Option Ex | 30,000 | 9.61 | 288,210 |
| 2020-11-13 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 48.00 | 48,000 |
| 2020-10-13 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 51.36 | 51,360 |
| 2020-10-09 | Nussbaum Robert L (Chief Medical Officer) | Option Ex | 6,550 | 9.90 | 64,845 |
| 2020-09-15 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 35.51 | 35,510 |
| 2020-09-10 | Brida Thomas (General Counsel) | Sale | 633 | 33.87 | 21,437 |
| 2020-09-10 | Stueland Katherine (Chief Commercial Officer) | Sale | 631 | 33.87 | 21,370 |
| 2020-09-10 | Nussbaum Robert L (Chief Medical Officer) | Sale | 23,175 | 33.85 | 784,404 |
| 2020-09-10 | George Sean E (President & CEO) | Sale | 742 | 33.87 | 25,129 |
| 2020-09-10 | Werner Robert F. (Chief Accounting Officer) | Sale | 246 | 33.87 | 8,331 |
| 2020-09-10 | Guyer Shelly D (Chief Financial Officer) | Sale | 631 | 33.87 | 21,370 |
| 2020-08-19 | Brida Thomas (General Counsel) | Sale | 12,416 | 32.10 | 398,503 |
| 2020-08-19 | Stueland Katherine (Chief Commercial Officer) | Sale | 21,345 | 32.10 | 685,110 |
| 2020-08-19 | Nussbaum Robert L (Chief Medical Officer) | Sale | 19,049 | 32.10 | 611,396 |
| 2020-08-19 | George Sean E (President & CEO) | Sale | 15,473 | 32.10 | 496,636 |
| 2020-08-19 | Werner Robert F. (Chief Accounting Officer) | Sale | 1,740 | 32.10 | 55,847 |
| 2020-08-19 | Guyer Shelly D (Chief Financial Officer) | Sale | 18,956 | 32.10 | 608,411 |
| 2020-08-12 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 29.31 | 29,310 |
| 2020-07-17 | Guyer Shelly D (Chief Financial Officer) | Sale | 12,000 | 33.38 | 400,512 |
| 2020-07-15 | Aguiar Eric (Director) | Sale | 10,000 | 33.84 | 338,390 |
| 2020-07-15 | Aguiar Eric (Director) | Option Ex | 10,000 | 8.08 | 80,800 |
| 2020-07-14 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 32.50 | 32,500 |
| 2020-07-13 | Bendekgey E Lee (Chief Operating Officer) | Sale | 27,500 | 34.12 | 938,162 |
| 2020-07-13 | Bendekgey E Lee (Chief Operating Officer) | Option Ex | 27,500 | 2.82 | 77,550 |
| 2020-07-09 | Nussbaum Robert L (Chief Medical Officer) | Sale | 29,783 | 34.21 | 1,018,757 |
| 2020-06-12 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 16.34 | 16,340 |
| 2020-06-03 | Nussbaum Robert L (Chief Medical Officer) | Option Ex | 20,000 | 9.90 | 198,000 |
| 2020-05-22 | Nussbaum Robert L (Chief Medical Officer) | Sale | 19,893 | 17.42 | 346,555 |
| 2020-05-20 | Brida Thomas (General Counsel) | Sale | 2,060 | 16.70 | 34,404 |
| 2020-05-20 | Stueland Katherine (Chief Commercial Officer) | Sale | 6,177 | 16.70 | 103,162 |
| 2020-05-20 | Nussbaum Robert L (Chief Medical Officer) | Sale | 6,864 | 16.70 | 114,635 |
| 2020-05-20 | George Sean E (President & CEO) | Sale | 25,500 | 16.70 | 425,875 |
| 2020-05-20 | Guyer Shelly D (Chief Financial Officer) | Sale | 5,250 | 16.70 | 87,680 |
| 2020-05-20 | Bendekgey E Lee (Chief Operating Officer) | Sale | 9,348 | 16.70 | 156,120 |
| 2020-05-13 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 17.56 | 17,560 |
| 2020-05-12 | Bendekgey E Lee (Chief Operating Officer) | Sale | 18,665 | 18.25 | 340,580 |
| 2020-04-13 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 12.80 | 12,803 |
| 2020-03-16 | Brida Thomas (General Counsel) | Sale | 9,226 | 11.79 | 108,774 |
| 2020-03-16 | Stueland Katherine (Chief Commercial Officer) | Sale | 10,684 | 11.79 | 125,964 |
| 2020-03-16 | Nussbaum Robert L (Chief Medical Officer) | Sale | 10,684 | 11.79 | 125,964 |
| 2020-03-16 | George Sean E (President & CEO) | Sale | 11,655 | 11.79 | 137,412 |
| 2020-03-16 | Guyer Shelly D (Chief Financial Officer) | Sale | 10,684 | 11.79 | 125,964 |
| 2020-03-16 | Bendekgey E Lee (Chief Operating Officer) | Sale | 11,056 | 11.79 | 130,350 |
| 2020-03-13 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 12.09 | 12,089 |
| 2020-02-27 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 20.43 | 20,435 |
| 2020-02-26 | Bendekgey E Lee (Chief Operating Officer) | Sale | 119,789 | 20.96 | 2,511,376 |
| 2020-02-26 | Bendekgey E Lee (Chief Operating Officer) | Option Ex | 85,963 | 7.01 | 602,944 |
| 2020-01-14 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 18.14 | 18,137 |
| 2019-12-13 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 17.08 | 17,082 |
| 2019-11-14 | Stueland Katherine (Chief Commercial Officer) | Sale | 3,788 | 17.46 | 66,123 |
| 2019-09-17 | Stueland Katherine (Chief Commercial Officer) | Sale | 3,788 | 21.41 | 81,082 |
| 2019-08-26 | Scott Randal W (Executive Chairman) | Sale | 40,000 | 24.42 | 976,760 |
| 2019-08-22 | Crouse Geoffrey (Director) | Sale | 5,000 | 25.68 | 128,410 |
| 2019-08-19 | Brida Thomas (General Counsel) | Sale | 13,663 | 25.29 | 345,591 |
| 2019-08-19 | Stueland Katherine (Chief Commercial Officer) | Sale | 22,900 | 25.29 | 579,232 |
| 2019-08-19 | Nussbaum Robert L (Chief Medical Officer) | Sale | 20,447 | 25.29 | 517,186 |
| 2019-08-19 | George Sean E (President & CEO) | Sale | 16,358 | 25.29 | 413,759 |
| 2019-08-19 | Guyer Shelly D (Chief Financial Officer) | Sale | 24,447 | 25.57 | 625,109 |
| 2019-08-19 | Bendekgey E Lee (Chief Operating Officer) | Sale | 21,265 | 25.29 | 537,876 |
| 2019-08-16 | Stueland Katherine (Chief Commercial Officer) | Sale | 3,789 | 24.98 | 94,645 |
| 2019-07-15 | Stueland Katherine (Chief Commercial Officer) | Sale | 3,789 | 22.49 | 85,229 |
| 2019-06-13 | Stueland Katherine (Chief Commercial Officer) | Sale | 3,789 | 19.36 | 73,355 |
| 2019-05-28 | Scott Randal W (Executive Chairman) | Sale | 30,000 | 17.60 | 528,030 |
| 2019-05-20 | Brida Thomas (General Counsel) | Sale | 2,146 | 18.21 | 39,078 |
| 2019-05-20 | Stueland Katherine (Chief Commercial Officer) | Sale | 6,474 | 18.21 | 117,891 |
| 2019-05-20 | Nussbaum Robert L (Chief Medical Officer) | Sale | 7,202 | 18.21 | 131,148 |
| 2019-05-20 | George Sean E (President & CEO) | Sale | 24,282 | 18.21 | 442,175 |
| 2019-05-20 | Guyer Shelly D (Chief Financial Officer) | Sale | 9,513 | 18.00 | 171,214 |
| 2019-05-20 | Bendekgey E Lee (Chief Operating Officer) | Sale | 6,851 | 18.21 | 124,756 |
| 2019-05-15 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 18.36 | 18,360 |
| 2019-05-14 | Bendekgey E Lee (Chief Operating Officer) | Sale | 4,657 | 18.78 | 87,439 |
| 2019-04-16 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 25.23 | 25,230 |
| 2019-03-15 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 23.49 | 23,490 |
| 2019-03-08 | Nussbaum Robert L (Chief Medical Officer) | Option Ex | 10,000 | 9.90 | 99,000 |
| 2019-02-27 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 19.61 | 19,610 |
| 2019-02-27 | Dumond Patty (See Remarks) | Sale | 5,000 | 19.71 | 98,539 |
| 2019-02-27 | Guyer Shelly D (Chief Financial Officer) | Sale | 4,000 | 20.22 | 80,868 |
| 2019-02-26 | Bendekgey E Lee (Chief Operating Officer) | Sale | 4,650 | 19.62 | 91,214 |
| 2019-02-25 | Scott Randal W (Executive Chairman) | Sale | 30,000 | 19.37 | 581,070 |
| 2019-01-16 | Dumond Patty (See Remarks) | Sale | 3,000 | 15.00 | 45,000 |
| 2019-01-16 | Guyer Shelly D (Chief Financial Officer) | Sale | 4,000 | 14.49 | 57,968 |
| 2019-01-15 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 13.59 | 13,590 |
| 2019-01-10 | Nussbaum Robert L (Chief Medical Officer) | Sale | 5,222 | 14.01 | 73,154 |
| 2018-12-17 | Stueland Katherine (Chief Commercial Officer) | Sale | 1,000 | 11.44 | 11,437 |
| 2018-11-27 | Aguiar Eric (Director) | Sale | 10,000 | 13.50 | 135,000 |
| 2018-11-16 | Dumond Patty (See Remarks) | Sale | 2,000 | 12.90 | 25,800 |
| 2018-09-20 | Dumond Patty (See Remarks) | Sale | 355 | 16.51 | 5,861 |
| 2018-09-18 | Dumond Patty (See Remarks) | Sale | 290 | 16.67 | 4,834 |
| 2018-09-09 | Stueland Katherine (Chief Commercial Officer) | Sale | 595 | 13.62 | 8,103 |
| 2018-05-15 | Brida Thomas (General Counsel) | Sale | 1,979 | 6.96 | 13,773 |
| 2018-05-15 | Stueland Katherine (Chief Commercial Officer) | Sale | 6,012 | 6.96 | 41,843 |
| 2018-05-15 | Nussbaum Robert L (Chief Medical Officer) | Sale | 6,702 | 6.96 | 46,645 |
| 2018-05-15 | Dumond Patty (See Remarks) | Sale | 5,014 | 6.96 | 34,897 |
| 2018-05-15 | George Sean E (President & CEO) | Sale | 20,311 | 6.96 | 141,364 |
| 2018-05-15 | Guyer Shelly D (Chief Financial Officer) | Sale | 5,135 | 6.96 | 35,739 |
| 2018-05-15 | Bendekgey E Lee (Chief Operating Officer) | Sale | 6,388 | 6.96 | 44,460 |
| 2018-04-02 | Scott Randal W (Executive Chairman) | Buy | 44,444 | 4.50 | 199,998 |
| 2018-03-28 | Baker Julian (10% Owner) | Buy | 1,111,111 | 4.50 | 4,999,999 |
| 2017-10-10 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Sale | 615 | 10.00 | 6,150 |
| 2017-10-09 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Sale | 1,882 | 10.00 | 18,820 |
| 2017-09-12 | Stueland Katherine (Chief Commercial Officer) | Sale | 612 | 9.40 | 5,752 |
| 2017-02-16 | Brida Thomas (General Counsel) | Sale | 766 | 9.69 | 7,420 |
| 2017-02-15 | Brida Thomas (General Counsel) | Sale | 794 | 9.54 | 7,573 |
| 2017-02-15 | Stueland Katherine (Chief Commercial Officer) | Sale | 911 | 9.50 | 8,655 |
| 2017-02-15 | Nussbaum Robert L (Chief Medical Officer) | Sale | 1,686 | 9.53 | 16,067 |
| 2017-02-15 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Sale | 1,264 | 9.55 | 12,068 |
| 2017-02-15 | Bendekgey E Lee (Chief Financial Officer) | Sale | 2,098 | 9.59 | 20,119 |
| 2017-01-03 | Nussbaum Robert L (Chief Medical Officer) | Option Ex | 1,666 | 1.26 | 2,099 |
| 2016-11-22 | Scott Randal W (Chairman and CEO) | Buy | 66,666 | 6.00 | 399,996 |
| 2016-11-18 | Crouse Geoffrey (Director) | Buy | 15,000 | 6.25 | 93,750 |
| 2016-11-18 | Aguiar Eric (Director) | Buy | 10,000 | 6.28 | 62,830 |
| 2016-11-17 | Baker Bros. Advisors (gp) Llc (10% Owner) | Buy | 733,333 | 6.00 | 4,399,998 |
| 2016-09-16 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Sale | 1,000 | 8.00 | 8,000 |
| 2016-09-16 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Option Ex | 1,000 | 3.42 | 3,420 |
| 2016-08-15 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Sale | 1,000 | 8.81 | 8,810 |
| 2016-08-15 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Option Ex | 1,000 | 2.82 | 2,820 |
| 2016-07-14 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Sale | 1,000 | 8.79 | 8,790 |
| 2016-07-14 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Option Ex | 1,000 | 2.82 | 2,820 |
| 2016-06-16 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Sale | 2,000 | 8.00 | 16,000 |
| 2016-06-16 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Option Ex | 2,000 | 2.82 | 5,640 |
| 2016-05-17 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Sale | 2,221 | 8.35 | 18,545 |
| 2016-05-16 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Sale | 1,000 | 8.73 | 8,730 |
| 2016-05-16 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Option Ex | 1,000 | 2.82 | 2,820 |
| 2016-04-14 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Sale | 1,000 | 10.50 | 10,500 |
| 2016-04-14 | Dumond Patty (VP Fin. & Principal Acct. Off.) | Option Ex | 1,000 | 2.82 | 2,820 |
| 2016-03-15 | Dumond Patty (VP Finance & PAO) | Sale | 1,000 | 8.59 | 8,590 |
| 2016-03-15 | Dumond Patty (VP Finance & PAO) | Option Ex | 1,000 | 2.82 | 2,820 |
| 2016-02-22 | Alderson Lisa (Chief Strategy Officer) | Sale | 7,500 | 7.64 | 57,285 |
| 2016-02-22 | Alderson Lisa (Chief Strategy Officer) | Option Ex | 7,500 | 3.42 | 25,650 |
| 2015-08-12 | George Sean E (President/COO) | Buy | 24,544 | 9.09 | 223,104 |
| 2015-08-11 | George Sean E (President/COO) | Buy | 25,355 | 9.22 | 233,773 |
| 2015-02-18 | Deerfield Special Situations Fund, L.p. | Buy | 175,000 | 16.00 | 2,800,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NVTA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Invitae Corp (symbol NVTA, CIK number 1501134) see the Securities and Exchange Commission (SEC) website.